| Financial Year |
March 31 2023 |
| Monetary Funds |
1,514,517,245.09 |
| Held-for-trading Financial Assets |
230,236,383.56 |
| Notes Receivable |
13,146,796.46 |
| Accounts Receivable |
278,888,401.90 |
| Advances to Suppliers |
4,999,646.08 |
| Other Receivables |
983,046.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
177,516,048.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,049,373.11 |
| Total Current Assets |
2,303,057,393.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,186,490.14 |
| Investment Properties |
-- |
| Fixed Assetes |
584,710,421.09 |
| Under-construction Projects |
11,588,327.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
49,246,531.56 |
| R&D expenses |
-- |
| Goodwill |
29,647,573.18 |
| Long-Term Deferred and Prepaid Expenses |
4,932,910.84 |
| Deferred Income Tax Assets |
12,876,776.75 |
| Other Non-Current Assets |
8,614,242.23 |
| Sub-Total of Non-Current Assets |
717,472,896.46 |
| Total Assets |
3,020,530,289.54 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
37,184,607.40 |
| Accounts Payable |
81,288,913.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
45,512,828.26 |
| Taxes Payable |
15,256,814.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
132,904.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,077,452.93 |
| Other Current Liabilities |
4,214,811.05 |
| Sub-Total of Current Liabilities |
219,510,233.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,427,947.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,817,451.07 |
| Total Liabilities |
249,327,684.24 |
| Paid-In Capital(Or Share Stock) |
393,975,113.00 |
| Capital Surplus |
1,046,934,141.23 |
| Surplus Reserve |
129,355,960.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,157,511,160.40 |
| Minority Stockholder's Interest |
53,101,374.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,718,101,230.63 |
| Owner's Equity（Stockholder's Equity） |
2,771,202,605.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,020,530,289.54 |
